Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real‐Life SettingMariele Gatto, Roberto Gerli, Micaela Fredi et al.|Arthritis & Rheumatology|2020Cited by 113
The role of WNT and IL-1 signaling in osteoarthritis: therapeutic implications for platelet-rich plasma therapyAntonio Tonutti, Angela Ceribelli, Veronica Marrella et al.|Frontiers in Aging|2023Cited by 21